| Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
| resourceType | ValueSet |
| id | 2.16.840.1.113762.1.4.1235.232 |
| canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1235.232 |
| version | 20230118 |
| status | active |
| publisher | B.well Connected Health Steward |
| name | InfluenzaVaccine_HD_CN_Grouping |
| title | Influenza Vaccine_HD_CN_Grouping |
| date | 2023-01-18T01:03:05-05:00 |
| description | b.well created value set by Sr. Clinical Business Analyst for the Influenza Vaccine - Adult Care Need. |
| Usages | (none) |
This value set contains 81 concepts
| Code | System | Display |
| 111 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, live, attenuated, for intranasal use |
| 120 | http://hl7.org/fhir/sid/cvx | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 127787002 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 135 | http://hl7.org/fhir/sid/cvx | influenza, high dose seasonal, preservative-free |
| 140 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable, preservative free |
| 141 | http://hl7.org/fhir/sid/cvx | Influenza, seasonal, injectable |
| 144 | http://hl7.org/fhir/sid/cvx | seasonal influenza, intradermal, preservative free |
| 146 | http://hl7.org/fhir/sid/cvx | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
| 148 | http://hl7.org/fhir/sid/cvx | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
| 149 | http://hl7.org/fhir/sid/cvx | influenza, live, intranasal, quadrivalent |
| 150 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, quadrivalent, preservative free |
| 153 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free |
| 155 | http://hl7.org/fhir/sid/cvx | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
| 158 | http://hl7.org/fhir/sid/cvx | influenza, injectable, quadrivalent, contains preservative |
| 161 | http://hl7.org/fhir/sid/cvx | Influenza, injectable,quadrivalent, preservative free, pediatric |
| 16292241000119109 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (procedure) |
| 166 | http://hl7.org/fhir/sid/cvx | influenza, intradermal, quadrivalent, preservative free, injectable |
| 168 | http://hl7.org/fhir/sid/cvx | Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
| 17 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 170343007 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170344001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170345000 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 170346004 | http://snomed.info/sct | Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure) |
| 171 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
| 185 | http://hl7.org/fhir/sid/cvx | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
| 186 | http://hl7.org/fhir/sid/cvx | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
| 197 | http://hl7.org/fhir/sid/cvx | influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
| 205 | http://hl7.org/fhir/sid/cvx | influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
| 310306005 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310307001 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 310308006 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312869001 | http://snomed.info/sct | Administration of vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 312870000 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Human poliovirus antigens (procedure) |
| 414001002 | http://snomed.info/sct | Administration of vaccine product containing only five component acellular Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 414259000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415507003 | http://snomed.info/sct | Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 415712004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type b and inactivated whole Human poliovirus antigens (procedure) |
| 46 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 50 | http://hl7.org/fhir/sid/cvx | DTaP-Haemophilus influenzae type b conjugate vaccine |
| 51 | http://hl7.org/fhir/sid/cvx | Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 770608009 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770616000 | http://snomed.info/sct | Administration of first dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770617009 | http://snomed.info/sct | Administration of second dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 770618004 | http://snomed.info/sct | Administration of third dose of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786846001 | http://snomed.info/sct | Administration of vaccine product containing only Haemophilus influenzae type b and Hepatitis B virus antigens (procedure) |
| 786847005 | http://snomed.info/sct | Administration of vaccine product containing only Influenza A virus subtype H5N1 antigen (procedure) |
| 787016008 | http://snomed.info/sct | Administration of vaccine product containing only Influenza virus antigen in nasal dose form (procedure) |
| 787436003 | http://snomed.info/sct | Administration of vaccine product containing only Bordetella pertussis and Clostridium tetani and Corynebacterium diphtheriae and Haemophilus influenzae type b antigens (procedure) |
| 86198006 | http://snomed.info/sct | Administration of vaccine product containing only Influenza virus antigen (procedure) |
| 88 | http://hl7.org/fhir/sid/cvx | influenza virus vaccine, unspecified formulation |
| 90630 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use |
| 90644 | http://www.ama-assn.org/go/cpt | Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (Hib-MenCY), 4 dose schedule, when administered to children 6 weeks-18 months of age, for intramuscular use |
| 90647 | http://www.ama-assn.org/go/cpt | Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use |
| 90648 | http://www.ama-assn.org/go/cpt | Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular use |
| 90653 | http://www.ama-assn.org/go/cpt | Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use |
| 90654 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use |
| 90655 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
| 90656 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
| 90657 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use |
| 90658 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use |
| 90660 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use |
| 90661 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
| 90662 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use |
| 90672 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use |
| 90673 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
| 90674 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use |
| 90682 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use |
| 90685 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use |
| 90686 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use |
| 90687 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use |
| 90688 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use |
| 90689 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use |
| 90694 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use |
| 90697 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use |
| 90698 | http://www.ama-assn.org/go/cpt | Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use |
| 90748 | http://www.ama-assn.org/go/cpt | Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use |
| 90756 | http://www.ama-assn.org/go/cpt | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use |
| G0008 | http://www.nlm.nih.gov/research/umls/hcpcs | Administration of influenza virus vaccine |
Produced 08 Sep 2023